scholarly journals Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver

2016 ◽  
Vol 6 (5) ◽  
pp. 453-459 ◽  
Author(s):  
Lai Peng ◽  
Stephanie Piekos ◽  
Grace L. Guo ◽  
Xiao-bo Zhong
2016 ◽  
Vol 39 (12) ◽  
pp. 2015-2021 ◽  
Author(s):  
Wataru Ochiai ◽  
Akiyo Hirose ◽  
Taisuke Kawamura ◽  
Kyoko Komachi ◽  
Yuka Yamamoto ◽  
...  

2014 ◽  
Vol 28 (S1) ◽  
Author(s):  
Lai Peng ◽  
Julia Cui ◽  
Byunggil Yoo ◽  
Yun‐chen Tien ◽  
Hong Lu ◽  
...  
Keyword(s):  
Phase I ◽  

1999 ◽  
Vol 79 ◽  
pp. 125
Author(s):  
Kiyoyuki Kitaichi ◽  
Li Wang ◽  
Haruna Kidokoro ◽  
Mitsunori Iwase ◽  
Kenji Takagi ◽  
...  

1972 ◽  
Vol 128 (2) ◽  
pp. 237-242 ◽  
Author(s):  
Sandra D. Atkin ◽  
Eileen D. Palmer ◽  
P. D. English ◽  
B. Morgan ◽  
M. A. Cawthorne ◽  
...  

1. Adjuvant-induced arthritis in rats is accompanied by a loss of activity of the drug-metabolizing enzyme system and a decrease in hepatic cytochrome P-450. 2. Arthritic rats have normal serum and liver cholesterol concentrations. 3. The rate of biogenesis of cholesterol in vivo and in vitro from either [14C]acetate or [14C]mevalonate in arthritic rats was the same as or greater than that found in control rats. 4. Treatment of rats with carbon disulphide (1ml/kg) resulted in a loss of drug-metabolizing-enzyme activity and increased cholesterol biogenesis. 5. The activity of cholesterol 7α-hydroxylase in adjuvant-induced arthritic rats did not differ significantly from that in control rats. 6. Rats fed with cholestyramine had an elevated hepatic cholesterol 7α-hydroxylase activity, but neither the concentration of cytochrome P-450 nor the activity of the drug-hydroxylating enzyme, aminopyrine demethylase, was affected. 7. The relationships between drug hydroxylation and cholesterol metabolism are discussed.


PLoS ONE ◽  
2011 ◽  
Vol 6 (3) ◽  
pp. e18046 ◽  
Author(s):  
Binu Shrestha ◽  
J. Michael Reed ◽  
Philip T. Starks ◽  
Gretchen E. Kaufman ◽  
Jared V. Goldstone ◽  
...  

1981 ◽  
Vol 200 (1) ◽  
pp. 35-42 ◽  
Author(s):  
N G Ibrahim ◽  
J C Nelson ◽  
R D Levere

The hepatic porphyrias are inborn errors of porphyrin and haem biosynthesis characterized biochemically by excessive excretion of delta-aminolaevulinate (ALA), porphobilinogen and other intermediates in haem synthesis. Clinical evidence has implicated iron in the pathogenesis of several types of genetically transmitted diseases. We investigated the role of iron in haem metabolism as well as its relationship to drug-mediated induction of ALA synthase and haem oxygenase in acute and chronic iron overload. Acute iron overload in rats resulted in a marked increase in hepatic haem oxygenase that was associated with a decrease in cytochrome P-450 and an increase in ALA synthase activity. Aminopyrine N-demethylase and aniline hydroxylase activities, which are dependent on the concentration of cytochrome P-450, were also decreased. In contrast, in chronic-iron-overloaded rats, there was an adaptive increase in haem oxygenase activity and an increase in ALA synthase that was associated with normal concentrations of microsomal haem and cytochrome P-450. The induction of ALA synthase in chronic iron overload was enhanced by phenobarbital and allylisopropylacetamide, in spite of the fact that these agents did not increase haem oxygenase activity. Small doses of Co2+ were potent inducers of the haem oxygenase in chronic-iron-overloaded, but not in control, animals. We conclude that increased hepatic cellular iron may predispose certain enzymes of haem synthesis to induction by exogenous agents and thereby affect drug-metabolizing enzyme activities.


Sign in / Sign up

Export Citation Format

Share Document